Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| cyanohydrin | CHEBI_23437 | [An alpha-hydroxynitrile resulting from the formal addition of hydrogen cyanide to the C=O bond of an aldehyde or ketone.] |
| 9(S)-HPODE(1-) | CHEBI_60955 | [A monocarboxylic acid anion obtained by removal of a proton from the carboxylic acid group of 9(S)-HPODE.] |
| 9(S)-HPODE | CHEBI_34498 | [An HPODE (hydroperoxy-octadecadienoic acid) in which the double bonds are at positions 10 and 12 (E and Z geometry, respectively) and the hydroperoxy group is at position 9 (S configuration). It is an intermediate in the metabolic pathway for linoleic acid.] |
| 9(R)-HPODE(1-) | CHEBI_63323 | [A monocarboxylic acid anion obtained by removal of a proton from the carboxylic acid group of 9(R)-HPODE.] |
| beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-GlcpNAc-OMe | CHEBI_145721 | [A methyl glycoside that is beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-GlcpNAc (LacLe(x)) in which the hydroxy group at the reducing-end anomeric centre is methylated.] |
| beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-Glcp-OMe | CHEBI_145722 | [A methyl glycoside that is beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-Glcp (RhaLac) in which the hydroxy group at the reducing-end anomeric centre is methylated.] |
| trifluoroacetic acid | CHEBI_45892 | [A monocarboxylic acid that is the trifluoro derivative of acetic acid.] |
| alpha-D-GalpNAc-(1->4)-D-GlcpNAc | CHEBI_60945 | [An amino disaccharide consisting of N-acetyl-D-glucosamine having an N-acetyl-alpha-D-galactosminyl resiude attached at the 4-position.] |
| 1,5-diazabicyclo[3.2.2]nonane | CHEBI_35989 | |
| diazabicyclononane | CHEBI_18945 | |
| N-[[(4S,5S)-8-(4-cyanophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylacetamide | CHEBI_106135 | |
| alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-Glc | CHEBI_60946 | [A linear trisaccharide comprising D-glucose (at the reducing end) having an alpha-D-galactosyl-(1->3)-beta-D-galactosyl moiety at the 4-position.] |
| N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide | CHEBI_106136 | |
| (2S)-2-[(4S,5R)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol | CHEBI_106137 | |
| alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-Glc | CHEBI_60948 | [A linear trisaccharide comprising D-glucose (at the reducing end) having an alpha-D-galactosyl-(1->4)-beta-D-galactosyl moiety at the 4-position.] |
| N-[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide | CHEBI_106138 | |
| alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-GlcNAc | CHEBI_60949 | [An amino trisaccharide consisting of two D-galactose residues and an N-acetyl-D-glucosamine residue (at the reducing end) in a linear sequence.] |
| (2R)-2-[(4R,5R)-8-(2-cyclohexylethynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol | CHEBI_106131 | |
| N-[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide | CHEBI_106132 | |
| (2R,3S)-8-(2-benzofuranyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one | CHEBI_106133 |